Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.
[Changes of epidemiological and clinical features and disease concept in multiple sclerosis].
Structural brain lesions in inflammatory bowel disease.
Using magnetic resonance imaging as a means to study chronic cerebral spinal venous insufficiency in multiple sclerosis patients.
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Optic neuritis revealing Kikuchi-Fujimoto disease.
Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.
Multiple sclerosis genetics.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis.
Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.
The fumaric acid ester BG-12: a new option in MS therapy.
Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.
Childhood inflammatory brain diseases: pathogenesis, diagnosis and therapy.
Validity of the RAI-MDS for ascertaining diabetes and comorbid conditions in long-term care facility residents.
Lymphomatoid papulosis: A cutaneous lymphoproliferative disorder in a patient on fingolimod for multiple sclerosis.
Cover Images.
Multiple sclerosis and the blood-central nervous system barrier.
Self-reported use of the upper limbs related to clinical tests in persons with multiple sclerosis.
Progressive degeneration of the retinal nerve fiber layer in patients with multiple sclerosis.
The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies.
Telephone-based physical activity counseling for major depression in people with multiple sclerosis.
Pages
« first
‹ previous
…
377
378
379
380
381
382
383
384
385
…
next ›
last »